| Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised … MS Hofman, N Lawrentschuk, RJ Francis, C Tang, I Vela, P Thomas, ... The Lancet 395 (10231), 1208-1216, 2020 | 1471 | 2020 |
| Enzalutamide with standard first-line therapy in metastatic prostate cancer ID Davis, AJ Martin, MR Stockler, S Begbie, KN Chi, S Chowdhury, ... New England Journal of Medicine 381 (2), 121-131, 2019 | 1291 | 2019 |
| Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ... European urology 73 (2), 178-211, 2018 | 866* | 2018 |
| Phytoestrogens AL Murkies, G Wilcox, SR Davis The Journal of Clinical Endocrinology & Metabolism 83 (2), 297-303, 1998 | 833 | 1998 |
| Laparoscopic and robotic‐assisted versus open radical prostatectomy for the treatment of localised prostate cancer D Ilic, SM Evans, CA Allan, JH Jung, D Murphy, M Frydenberg Cochrane Database of Systematic Reviews, 2017 | 311 | 2017 |
| Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer MJ Watt, AK Clark, LA Selth, VR Haynes, N Lister, R Rebello, LH Porter, ... Science translational medicine 11 (478), eaau5758, 2019 | 284 | 2019 |
| Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial A Kneebone, C Fraser-Browne, GM Duchesne, R Fisher, M Frydenberg, ... The Lancet Oncology 21 (10), 1331-1340, 2020 | 272 | 2020 |
| Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy? JP Grummet, M Weerakoon, S Huang, N Lawrentschuk, M Frydenberg, ... BJU international 114 (3), 384-388, 2014 | 270 | 2014 |
| Defining a standard set of patient-centered outcomes for men with localized prostate cancer NE Martin, L Massey, C Stowell, C Bangma, A Briganti, A Bill-Axelson, ... European urology 67 (3), 460-467, 2015 | 249 | 2015 |
| Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories RA Taylor, M Fraser, J Livingstone, SMG Espiritu, H Thorne, V Huang, ... Nature communications 8 (1), 13671, 2017 | 236 | 2017 |
| Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 … GM Duchesne, HH Woo, JK Bassett, SJ Bowe, C D'Este, M Frydenberg, ... The Lancet Oncology 17 (6), 727-737, 2016 | 222 | 2016 |
| Local aromatase expression in human prostate is altered in malignancy SJ Ellem, JF Schmitt, JS Pedersen, M Frydenberg, GP Risbridger The Journal of Clinical Endocrinology & Metabolism 89 (5), 2434-2441, 2004 | 217 | 2004 |
| Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men RI McLachlan, L O’Donnell, PG Stanton, G Balourdos, M Frydenberg, ... The Journal of Clinical Endocrinology & Metabolism 87 (2), 546-556, 2002 | 214 | 2002 |
| The role of magnetic resonance imaging in the diagnosis and management of prostate cancer J Thompson, N Lawrentschuk, M Frydenberg, L Thompson, P Stricker, ... BJU international 112, 6-20, 2013 | 202 | 2013 |
| Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer FS Dalais, A Meliala, N Wattanapenpaiboon, M Frydenberg, DAI Suter, ... Urology 64 (3), 510-515, 2004 | 187 | 2004 |
| Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones RA Jarred, M Keikha, C Dowling, SJ McPherson, AM Clare, AJ Husband, ... Cancer Epidemiology Biomarkers & Prevention 11 (12), 1689-1696, 2002 | 187 | 2002 |
| EAU-ESMO Consensus statements on the management of advanced and variant bladder cancer—an international collaborative multistakeholder effort†: under the auspices of the EAU … JA Witjes, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ... European urology 77 (2), 223-250, 2020 | 183 | 2020 |
| Active surveillance for prostate cancer: a narrative review of clinical guidelines SM Bruinsma, CH Bangma, PR Carroll, MS Leapman, A Rannikko, ... Nature Reviews Urology 13 (3), 151-167, 2016 | 183 | 2016 |
| Investigations with FDG-PET scanning in prostate cancer show limited value for clinical practice E Salminen, A Hogg, D Binns, M Frydenberg, R Hicks Acta Oncologica 41 (5), 425-429, 2002 | 154 | 2002 |
| Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor … GP Risbridger, RA Taylor, D Clouston, A Sliwinski, H Thorne, S Hunter, ... European Urology 67 (3), 496-503, 2015 | 153 | 2015 |
